|
Novalyst, AliX, and the renowned IGBMC, Institute of Genetics and Molecular and Cellular Biology (Illkirch-Graffenstaden, France), have joined forces to discover novel molecules for a newly identified target.
This project called NOVALIX received a label from the globally-oriented competitiveness cluster “Innovations thérapeutiques”, coordinated by Alsace Biovalley.
|